Pulmatrix Stock Price on November 19, 2024
| PULM Stock | USD 6.29 0.25 4.14% |
Below is the normalized historical share price chart for Pulmatrix extending back to March 21, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pulmatrix stands at 6.29, as last reported on the 26th of November, with the highest price reaching 6.32 and the lowest price hitting 5.97 during the day.
If you're considering investing in Pulmatrix Stock, it is important to understand the factors that can impact its price. Pulmatrix is very risky given 3 months investment horizon. Pulmatrix maintains Sharpe Ratio (i.e., Efficiency) of 0.19, which implies the firm had a 0.19% return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.27% are justified by taking the suggested risk. Use Pulmatrix Risk Adjusted Performance of 0.1541, semi deviation of 3.24, and Coefficient Of Variation of 527.86 to evaluate company specific risk that cannot be diversified away.
At this time, Pulmatrix's Total Stockholder Equity is very stable compared to the past year. As of the 26th of November 2024, Common Stock Shares Outstanding is likely to grow to about 3.8 M, while Common Stock Total Equity is likely to drop 4.37. . At this time, Pulmatrix's Price Book Value Ratio is very stable compared to the past year. As of the 26th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.02, while Price Earnings Ratio is likely to drop (0.51). Pulmatrix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of March 2014 | 200 Day MA 2.1332 | 50 Day MA 2.6576 | Beta 0.988 |
Pulmatrix |
Sharpe Ratio = 0.1933
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | PULM | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.75 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.27 actual daily | 45 55% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Pulmatrix is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pulmatrix by adding it to a well-diversified portfolio.
Price Book 2.0201 | Enterprise Value Ebitda 1.5719 | Price Sales 1.9364 | Shares Float 3.7 M | Wall Street Target Price 10 |
Related Headline
Bio Path Headline on 19th of November 2024
Antisense and RNAi Therapeutics Market Research Report 2024 ... by finance.yahoo.com
Antisense and RNAi Therapeutics Market Antisense and RNAi Therapeutics Market Dublin, Nov. 19, 2024 -- The Antisense and RNAi Therapeutics - Global Strategic Business Report report has been added to ResearchAndMarkets.coms offering.The global market for Antisense and RNAi Therapeutics was estimated at US2.1 Billion in 2023 and is projected to reach US3.6 Billion by 2030, growing at a CAGR of 8.1 percent from 2023 to 2030. This comprehensive report provides an in-depth analysis of
Pulmatrix Valuation on November 19, 2024
It is possible to determine the worth of Pulmatrix on a given historical date. On November 19, 2024 Pulmatrix was worth 6.7 at the beginning of the trading date compared to the closed value of 5.43. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pulmatrix stock. Still, in general, we apply an absolute valuation method to find Pulmatrix's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pulmatrix where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pulmatrix's related companies.
| Open | High | Low | Close | Volume | |
| 7.10 | 8.44 | 6.66 | 6.72 | 1,439,479 | |
11/19/2024 | 6.70 | 6.70 | 5.28 | 5.43 | 547,269 |
| 5.35 | 6.40 | 5.35 | 5.62 | 245,084 |
| Backtest Pulmatrix | | | Pulmatrix History | | | Pulmatrix Valuation | Previous | Next |
Pulmatrix Trading Date Momentum on November 19, 2024
| On November 20 2024 Pulmatrix was traded for 5.62 at the closing time. The top price for the day was 6.40 and the lowest listed price was 5.35 . The trading volume for the day was 245.1 K. The trading history from November 20, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 3.50% . The trading delta at closing time against the current closing price is 13.81% . |
Pulmatrix Fundamentals Correlations and Trends
By evaluating Pulmatrix's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pulmatrix's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pulmatrix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pulmatrix Stock history
Pulmatrix investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pulmatrix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pulmatrix will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pulmatrix stock prices may prove useful in developing a viable investing in Pulmatrix
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.7 M | 3.8 M | |
| Net Loss | -17 M | -17.8 M |
Pulmatrix Quarterly Net Working Capital |
|
Pulmatrix Stock Technical Analysis
Pulmatrix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pulmatrix Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Pulmatrix cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pulmatrix November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Pulmatrix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pulmatrix shares will generate the highest return on investment. By undertsting and applying Pulmatrix stock market strength indicators, traders can identify Pulmatrix entry and exit signals to maximize returns
Pulmatrix Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pulmatrix's price direction in advance. Along with the technical and fundamental analysis of Pulmatrix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pulmatrix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1541 | |||
| Jensen Alpha | 2.24 | |||
| Total Risk Alpha | 0.386 | |||
| Sortino Ratio | 0.4564 | |||
| Treynor Ratio | (4.44) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.64) | Revenue Per Share 3.119 | Quarterly Revenue Growth (0.16) | Return On Assets (0.30) | Return On Equity (0.59) |
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.